Biosimilar Awareness Week 2022

Biosimilar Awareness Week is an opportunity for healthcare professionals and the Australian public to engage in a conversation about biosimilar medicines and their role in supporting the future of sustainable healthcare for all Australians.

Hear from Independent Chair of GBMA, Professor Jane Halton AO PSM, discussing #BiosimilarAwarenessWeek2022 and the role of biosimilar medicines in supporting a sustainable Australian healthcare system. Watch here.

Please share our Biosimilar Awareness Week posts on Facebook, LinkedIn, and Twitter.

Share on Facebook

Biosimilar Awareness Week

Welcome to Biosimilar Awareness Week 2022! A week that aims to raise awareness about biosimilar medicines and the role they play in offering patient choice and providing substantial cost-reductions to help maintain our world leading Australian healthcare system.

Every day this week we will be sharing educational and important content to help support you through your biosimilar journey.

Stay tuned for more updates, and in the meantime visit the Biosimilar Hub for more resources: https://biosimilarhub.com.au

#BiosimilarMedicines #AustralianHealthcare #HealthcareProfessionals

Do you know the benefits of biosimilar medicines?

Do you know the benefits of biosimilar medicines? 

Its Biosimilar Awareness Week and the perfect time to learn more about  biosimilar medicines and how they can help create a more sustainable  Australian healthcare system.  

A biosimilar medicine is a highly similar version of an original brand of  medicine. Introduction into the market provides competition and can trigger  price reductions to the PBS through a process called Price Disclosure. 

This means the Government can re-invest savings into other new treatments and health care services – like childcare, eldercare, mental health services,  research and more.  

To learn more about how biosimilar medicines can contribute to the future  sustainability of the Australian healthcare system, visit: biosimilarhub.com.au #BiosimilarAwarenessWeek2022

Do you suffer from diabetes, severe psoriasis, rheumatoid arthritis, inflammatory bowel disease, Crohn’s disease or kidney disease?

Do you suffer from diabetes, severe psoriasis, rheumatoid arthritis, inflammatory bowel disease, Crohn’s disease or kidney disease? 

All of these conditions can be treated using biosimilar medicines. 

Biosimilar medicines can help reduce costs of the Australian healthcare system. 

This Biosimilar Awareness Week, learn more about how you can access biosimilar medicines at: https://biosimilarhub.com.au/consumer/faq/

Have you had a chat with your doctor about switching to a biosimilar medicine?

Have you had a chat with your doctor about switching to a biosimilar medicine? 

Ultimately, it’s up to you and your doctor to determine if biosimilar medicines are right for you. 

However, did you know that biosimilar medicines have the potential to generate substantial cost- reductions for the Australian healthcare system?

This Biosimilar Awareness Week, learn more about how biosimilar medicines can help maintain a world-class healthcare system for the future. 

Visit the Biosimilar Hub to learn more about biosimilar medicines: https://biosimilarhub.com.au

Jane Halton AO PSM

“Biosimilars play an increasingly important role in Australia’s healthcare strategy – which is why Biosimilar Awareness Week is a crucial element of the GBMA Education program – facilitating broader understanding amongst the general public and with healthcare professionals to protect the future of our healthcare system” 

Jane Halton, AO PSM, Independent Chair of GBMA has reflected on the exciting activities and important information shared this past week for Biosimilar Awareness Week 2022.

Though today is the final day, there is still so much more to learn and uncover about biosimilar medicines.

Become #BiosimilarAware by visiting the Biosimilar Hub and following our social channels to stay up to the date with the latest biosimilar medicines news.

Visit the Biosimilar Hub: https://biosimilarhub.com.au/

#BiosimilarMedicines #AustralianHealthcare #HealthcareProfessionals

Thank You!

Biosimilar Awareness Week 2022 has flown by and we can’t believe today is the final day!

However, being #BiosimilarAware isn’t just for one week, and the Biosimilar Hub will continue to host a wealth of educational resources for consumers.

Beyond this, it provides real stories and experiences of patients using biosimilar medicines, expert insights from healthcare professionals, and also the latest news, updates and general information on biosimilar medicines.

To receive the latest updates on everything biosimilar medicines, register here: https://biosimilarhub.com.au/consumer/stay-in-touch/ 

We want to thank you for your continued support, and we can’t wait to see what the future of biosimilar medicines brings! 

#BiosimilarMedicines #AustralianHealthcare #HealthcareProfessionals

Share on LinkedIn

Biosimilar Awareness Week

Welcome to #BiosimilarAwarenessWeek2022! A week that aims to raise awareness about biosimilar medicines and the role they play in helping to contribute to a more sustainable Australian healthcare system.
This year the awareness week will focus on offering support to healthcare professionals as we continue to see biosimilars emerge as an important option both for patients and our healthcare system.
Every day this week we will be sharing educational and important content – and we will be hearing directly from healthcare professionals and their patients on their experiences with biosimilar medicines.

Stay tuned for more updates and in the meantime visit the Biosimilar Hub for more resources: https://biosimilarhub.com.au

#BiosimilarMedicines #AustralianHealthcare #HealthcareProfessionals

Do you want to play a part in creating a sustainable healthcare system?

Do you want to play a part in creating a sustainable healthcare system in Australia?

Prescribing biosimilars offer patient choice and have the potential to  generate substantial cost-reductions for our healthcare system through  price disclosure arrangements mandated by the PBS which ensure that  prices for brands more closely reflect the prices in the market and  encourage market competition.

Listen to a group of independent experts discuss the benefits and cost  savings and benefits of biosimilar medicines:

https://biosimilarhub.com.au/benefits-and-cost-savings/ #BiosimilarAwarenessWeek2022

Have you considered prescribing biosimilar medicines to your patients?

Do you want to play a part in creating a sustainable healthcare system in Australia?

Prescribing biosimilars offer patient choice and have the potential to generate substantial cost-reductions for our healthcare system through price disclosure arrangements mandated by the PBS which ensure that prices for brands more closely reflect the prices in the market and encourage market competition.

Listen to a group of independent experts discuss the benefits and cost savings and benefits of biosimilar medicines:

https://biosimilarhub.com.au/benefits-and-cost-savings/ #BiosimilarAwarenessWeek2022

Do you know when you can prescribe a biosimilar medicine?

Have you considered prescribing biosimilar medicines to your patients? 

It’s #BiosimilarAwarenessWeek2022 and the perfect time to consider if biosimilar medicines might be right for your patients.

Switching to a biosimilar medicine is a choice which can help contribute to a more sustainable healthcare system. Patients who switch to a biosimilar medicine can expect a comparable clinical result. 

Learn more here: https://biosimilarhub.com.au 

#BiosimilarMedicines #HealthcareProfessionals #AustralianHealthcare

Jane Halton AO PSM

“Biosimilars play an increasingly important role in Australia’s healthcare strategy – which is why Biosimilar Awareness Week is a crucial element of the GBMA Education program – facilitating broader understanding amongst the general public and with healthcare professionals to protect the future of our healthcare system” 

Jane Halton AO PSM, Independent Chair of GBMA, has reflected on the activities and important information shared this past week for #BiosimilarAwarenessWeek2022. Though today is the final day of Biosimilar Awareness Week, there is still so much more to learn and uncover about biosimilar medicines. Become #BiosimilarAware by visiting the Biosimilar Hub and following our social channels to stay up to date with the latest biosimilar medicines news.

Visit the Biosimilar Hub: https://biosimilarhub.com.au

#BiosimilarMedicines #AustralianHealthcare #HealthcareProfessionals

Thank You!

Today marks the end of #BiosimilarAwarenessWeek2022 – thank you for your support! 

However – being #BiosimilarAware isn’t just for one week – and the Biosimilar Hub will continue to host a wealth of educational resources for consumers, carers and healthcare professionals. Beyond this, it provides real stories and experiences of patients using biosimilar medicines, expert insights from healthcare professionals, and also the latest news, updates and general information on biosimilars.

To receive the latest updates on everything biosimilar medicines, register here: https://biosimilarhub.com.au/consumer/stay-in-touch/

We want to thank you for your continued support, and we can’t wait to see what the future of biosimilar medicines brings! 

#BiosimilarMedicines #AustralianHealthcare #HealthcareProfessionals

Share on Twitter

Biosimilar Awareness Week

Welcome to #BiosimilarAwarenessWeek2022! A week that aims to raise awareness about #biosimilarmedicines & the role they play in helping to contribute to a more sustainable healthcare system.

Stay tuned this week & visit the Biosimilar Hub for more info: https://biosimilarhub.com.au

Do you want to play a part in creating a sustainable healthcare system?

Do you want to play a part in creating a sustainable Australian healthcare system? Prescribing assist by driving down the cost of medicines via a process called #PriceDisclosure. Check this fact sheet for more: https://bit.ly/3vrKlzB

Have you considered prescribing biosimilar medicines to your patients?

Have you considered prescribing biosimilar medicines to your patients? It’s #BiosimilarAwarenessWeek and the perfect time to consider if biosimilar medicines might be right for your patients. Learn more here: https://biosimilarhub.com.au

Do you know when you can prescribe a biosimilar medicine?

Do you know when you can prescribe a biosimilar medicine? There are 3 main scenarios physicians should be aware of this Biosimilar Awareness Week Consider if biosimilar medicines might be right for your patients and find out more at https://biosimilarhub.com.au/

Jane Halton AO PSM

Jane Halton AO PSM, Independent Chair of GBMA has reflected on the exciting activities & important information shared this past week for #BiosimilarAwarenessWeek2022. Stay #BiosimilarAware by visiting the Biosimilar Hub and following our social channels – https://biosimilarhub.com.au/

Help us raise awareness by posting one of the following facts on your social pages

You can also show your support by joining the @BiosimilarsAu community on LinkedIn, Twitter and Facebook